Immunoconversion against Sarcocystis neurona in normal and dexamethasone-treated horses challenged with S. neurona sporocysts.
Equine protozoal myeloencephalitis is a common neurologic disease of horses in the Americas usually caused by Sarcocystis neurona. To date, the disease has not been induced in horses using characterized sporocysts from Didelphis virginiana, the definitive host. S. neurona sporocysts from 15 naturally infected opossums were fed to horses seronegative for antibodies against S. neurona. Eight horses were given 5x10(5) sporocysts daily for 7 days. Horses were examined for abnormal clinical signs, and blood and cerebrospinal fluid were harvested at intervals for 90 days after the first day of challenge and analyzed both qualitatively (western blot) and quantitatively (anti-17kDa) for anti-S. neurona IgG. Four of the challenged horses were given dexamethasone (0.1mg/kg orally once daily) for the duration of the experiment. All challenged horses immunoconverted against S. neurona in blood within 32 days of challenge and in CSF within 61 days. There was a trend (P = 0.057) for horses given dexamethasone to immunoconvert earlier than horses that were not immunosuppressed. Anti-17kDa was detected in the CSF of all challenged horses by day 61. This response was statistically greater at day 32 in horses given dexamethasone. Control horses remained seronegative throughout the period in which all challenged horses converted. One control horse immunoconverted in blood at day 75 and in CSF at day 89. Signs of neurologic disease were mild to equivocal in challenged horses. Horses given dexamethasone had more severe signs of limb weakness than did horses not given dexamethasone; however, we could not determine whether these signs were due to spinal cord disease or to effects of systemic illness. At necropsy, mild-moderate multifocal gliosis and neurophagia were found histologically in the spinal cords of 7/8 challenged horses. No organisms were seen either in routinely processed sections or by immunohistochemistry. Although neurologic disease comparable to naturally occurring equine protozoal myeloencephalitis (EPM) was not produced, we had clear evidence of an immune response to challenge both systemically and in the CNS. Broad immunosuppression with dexamethasone did not increase the severity of histologic changes in the CNS of challenged horses. Future work must focus on defining the factors that govern progression of inapparent S. neurona infection to EPM.
Department of Pathobiology, PO Box 100880, College of Veterinary Medicine, University of Florida, Gainesville 32610, USA.
T J
TJ
Cutler
R J
RJ
MacKay
P E
PE
Ginn
K
K
Gillis
S M
SM
Tanhauser
E V
EV
LeRay
J B
JB
Dame
E C
EC
Greiner
D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D001344:Autopsy / Q000662:veterinary; D015153:Blotting, Western / Q000662:veterinary; D003907:Dexamethasone / Q000494:pharmacology*; D004679:Encephalomyelitis / Q000276:immunology / Q000662:veterinary*; D005065:Euthanasia / Q000662:veterinary; D006734:Horse Diseases / Q000276:immunology*; D006736:Horses; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008970:Molecular Weight; D009893:Opossums / Q000469:parasitology*; D016133:Polymerase Chain Reaction / Q000662:veterinary; D012523:Sarcocystosis / Q000276:immunology / Q000662:veterinary*
D000913:Antibodies, Protozoan; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D003907:Dexamethasone